STAT

The modern tragedy of fake cancer cures

In medicine, virality means false hopes, dashed dreams, and a whole lot of hype. We are desperate for a solution.

So it happened again. An underreported story about a half-baked advance in cancer medicine caught fire and scorched its way through social media, onto network TV, and into the minds of millions of people.

To start, no. There won’t be “a complete cure for cancer” in a year’s time, as the chairman of a small Israeli biotechnology firm predicted to the Jerusalem Post. The claim, absurd on its face, was particularly frustrating to those who

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Plans For Generic Wegovy, Cough Syrup Warnings, And More
Biocon is developing a generic version of Novo Nordisk's Wegovy and is prepared to conduct a clinical trial next year if needed.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.

Related Books & Audiobooks